A Study to Assess Effectiveness and Safety of Fixed Dose Combination of Lopinavir/Ritonavir (LPV/r) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected Patients After Switching From Kaletra in the Routine Clinical Settings of Russian Federation

Clinical Study to Evaluate the Efficacy and Safety of Lopinavir/Ritonavir Monotherapy Versus Darunavir/Ritonavir Monotherapies as Simplification Switching Strategies of PI/NNRTI-Triple Therapy Based-Regimens

NCT00994344 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy of Kaletra in ARV Therapy Experienced Patients

NCT00648999 ·Status: COMPLETED ·Phase: PHASE4

High Dose Ritonavir/Lopinavir Liquid Formulation in Salvage Therapy for Protease Inhibitor Resistant HIV Disease

NCT00247143 ·Status: UNKNOWN ·Phase: NA

Multicountry, Multicenter Post-Marketing Observational Study of Clinical, Biological and Virological Outcomes, Compliance and Tolerability of Kaletra® in Routine Clinical Use

NCT01379703 ·Status: COMPLETED

Study of the 48-Week Virologic and Immunologic Response to Lopinavir/Ritonavir (Kaletra) in HIV Positive Adult Patients

NCT00116636 ·Status: COMPLETED ·Phase: PHASE2

Long-term Effectiveness and Safety in Hepatitis-co-infected Patients

NCT01153269 ·Status: COMPLETED

Study of Lopinavir/ Ritonavir and Lamivudine Versus Standard Therapy in Naïve HIV-1 Infected Subjects.

NCT01237444 ·Status: COMPLETED ·Phase: PHASE3

Amprenavir/Ritonavir or Saquinavir/Ritonavir in HIV-Infected Subjects Following Failure With Kaletra as Their Second Protease Inhibitor

NCT00038519 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Trial About Hepatic Security of Antiretroviral Treatment Based on Kaletra Versus Nevirapine in Co-infected HIV/HCV Patients

NCT00661349 ·Status: TERMINATED ·Phase: PHASE4

Lopinavir Capsules to Kaletra or Invirase Tablets

NCT00438152 ·Status: COMPLETED ·Phase: PHASE4

A Simplified Kaletra® (Lopinavir/Ritonavir)-Based Therapy Versus a Sustiva® (Efavirenz)-Based Standard of Care in Previously Non-Treated HIV-Infected Subjects

NCT00075231 ·Status: COMPLETED ·Phase: PHASE2

BOOST: Study of Increased Dosage of Lopinavir/Ritonavir (LPV/r)

NCT00414284 ·Status: TERMINATED ·Phase: PHASE4

Study on the Effect of Kaletra + Nevirapine as Maintenance Bitherapy Compared to a Triple Therapy Including Kaletra + Analogues in HIV Patients

NCT00335686 ·Status: COMPLETED ·Phase: PHASE4

A Study Exploring an Induction-Maintenance Kaletra-Based Therapy Versus a Sustiva-Based Regimen in Previously Non-Treated, HIV-1/HCV Co-Infected Subjects

NCT00121017 ·Status: WITHDRAWN ·Phase: PHASE2

Comparison of Treatment Simplification by LPV/r vs Current Treatment Continuation in HIV-Infected Patients

NCT00140751 ·Status: COMPLETED ·Phase: PHASE3

Drug Use Investigation of Kaletra Tablets (Once Daily Administration) on Patients With HIV-infection

NCT01328158 ·Status: COMPLETED

Study of Lopinavir/Ritonavir Tablets Comparing Once-Daily Versus Twice-Daily Administration When Coadministered With Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Antiretroviral-Experienced Human Immunodeficiency Virus Type 1 Infected Subjects

NCT00358917 ·Status: COMPLETED ·Phase: PHASE3

Comparison of Two Dosing Regimens of GW433908/Ritonavir Versus Lopinavir/Ritonavir for 48 Weeks in HIV Patients Who Have Taken Protease Inhibitors and Experienced Virological Failure

NCT00025727 ·Status: UNKNOWN ·Phase: PHASE3

A Randomised Trial to Evaluate the Antiviral Efficacy and Safety of Treatment With 500 mg Tipranavir (TPV) Plus 100 mg or 200 mg Ritonavir (RTV) p.o. BID in Comparison to 400 mg Lopinavir (LPV) Plus 100 mg RTV p.o. BID in Combination With Standard Background Regimen in ARV Therapy naïve Patients.

NCT00144105 ·Status: TERMINATED ·Phase: PHASE2

GW873140 In Combination With Kaletra In HIV Infected Subjects

NCT00102778 ·Status: TERMINATED ·Phase: PHASE2

Drug Use Investigation of Kaletra

NCT01076972 ·Status: COMPLETED

Study to Evaluate the Activity and Tolerability of Lopinavir/Ritonavir and Lamivudine Bitherapy in HIV Patients With Viral Suppression

NCT01471821 ·Status: COMPLETED ·Phase: PHASE4

TMC114-C214: Trial of TMC114 Administered With Low Dose Ritonavir (RTV) in HIV-1 Infected Treatment Experienced Patients

NCT00110877 ·Status: COMPLETED ·Phase: PHASE3

MK0518 in the Treatment of HIV-Infected Patients Switched From a Protease Inhibitor Regimen (0518-033)(TERMINATED)

NCT00443729 ·Status: TERMINATED ·Phase: PHASE3

Evaluation of Kaletra Therapy Over the Long-term

NCT01083810 ·Status: COMPLETED